This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Walter H. Kaye, MD; Wade Berrettini, MD; Harry Gwirtsman, MD; David T. George, MD

Arch Gen Psychiatry. 1990;47(6):548-556.

Abstract
• The related central nervous system peptides neuropeptide Y and peptide YY have been found to be among the most potent endogenous stimulants of feeding behavior. We measured these neuropeptides in cerebrospinal fluid to determine whether they contributed to the pathophysiologic characteristics of anorexia and bulimia nervosa. Cerebrospinal fluid neuropeptide Y concentrations were significantly elevated in underweight anorectic patients and in many of the anorectic patients studied at intervals after weight restoration. These levels normalized in long-term weight-restored anorectic patients who had a return of normal menstrual cycles. Increased neuropeptide Y activity may contribute to several characteristic disturbances in anorexia, including menstrual dysregulation. Cerebrospinal fluid peptide YY concentrations were significantly elevated in normal-weight bulimic patients abstinent from pathological eating behavior for a month compared with themselves when actively bingeing and vomiting or compared with healthy volunteers. Increased peptide YY activity may contribute to a drive to overfeed in normal-weight bulimic patients.

Author Affiliations
From the Western Psychiatric Institute and Clinic, University of Pittsburgh (Pa) (Dr Kaye); the Clinical Neurogenetics Branch, Intramural Research Program (Dr Berrettini), and the National Institute of Alcohol Abuse and Alcoholism (Dr George), National Institute of Mental Health, Bethesda, Md; and the Neuropsychiatric Institute, UCLA (Dr Gwirtsman).

Footnotes
Accepted for publication August 17, 1989.

Read before the American College of Neuropsychopharmacology Meeting, San Juan, Puerto Rico, December 16, 1988.

Reprint requests to Western Psychiatric Institute and Clinic, 3811 O'Hara St, Room E-724, Pittsburgh, PA 15213 (Dr Kaye).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Differential regulation of agouti-related protein and neuropeptide Y in hypothalamic neurons following a stressful event
Kas et al.
J Mol Endocrinol 2005;35:159-164.
ABSTRACT | FULL TEXT  

Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ
INUI et al.
FASEB J. 2004;18:439-456.
ABSTRACT | FULL TEXT  

Centrally administered neuropeptide Y delays gastric emptying via Y2 receptors in rats
Ishiguchi et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001;281:R1522-R1530.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid and Plasma Concentrations of Leptin, NPY, and {alpha}-MSH in Obese Women and Their Relationship to Negative Energy Balance
Nam et al.
J. Clin. Endocrinol. Metab. 2001;86:4849-4853.
ABSTRACT | FULL TEXT  

Neuropeptide Y induces fasted pattern of duodenal motility via Y2 receptors in conscious fed rats
Fujimiya et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2000;278:G32-G38.
ABSTRACT | FULL TEXT